367 related articles for article (PubMed ID: 12666094)
1. Limitations of current Parkinson's disease therapy.
Rascol O; Payoux P; Ory F; Ferreira JJ; Brefel-Courbon C; Montastruc JL
Ann Neurol; 2003; 53 Suppl 3():S3-12; discussion S12-5. PubMed ID: 12666094
[TBL] [Abstract][Full Text] [Related]
2. Role of surgery in the treatment of motor complications.
Metman LV; O'Leary ST
Mov Disord; 2005; 20 Suppl 11():S45-56. PubMed ID: 15822076
[TBL] [Abstract][Full Text] [Related]
3. Parkinson's disease, subthalamic stimulation, and selection of candidates: a pathological study.
Jarraya B; Bonnet AM; Duyckaerts C; Houeto JL; Cornu P; Hauw JJ; Agid Y
Mov Disord; 2003 Dec; 18(12):1517-20. PubMed ID: 14673889
[TBL] [Abstract][Full Text] [Related]
4. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
5. [Neurosurgical treatment for dopamine-induced dyskinesias in Parkinson's disease patients].
Sugiyama K; Yokoyama T; Namba H
Nihon Rinsho; 2000 Oct; 58(10):2115-9. PubMed ID: 11068457
[TBL] [Abstract][Full Text] [Related]
6. Globus pallidus stimulation in advanced Parkinson's disease.
Rodrigues JP; Walters SE; Watson P; Stell R; Mastaglia FL
J Clin Neurosci; 2007 Mar; 14(3):208-15. PubMed ID: 17150360
[TBL] [Abstract][Full Text] [Related]
7. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
8. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
Bejjani BP; Arnulf I; Demeret S; Damier P; Bonnet AM; Houeto JL; Agid Y
Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease.
Vitek JL; Bakay RA; Freeman A; Evatt M; Green J; McDonald W; Haber M; Barnhart H; Wahlay N; Triche S; Mewes K; Chockkan V; Zhang JY; DeLong MR
Ann Neurol; 2003 May; 53(5):558-69. PubMed ID: 12730989
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced Parkinson's disease.
Diamond A; Jankovic J
Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
[TBL] [Abstract][Full Text] [Related]
11. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacological therapy of complicated Parkinson's disease].
Jiménez-Jiménez FJ; Molina JA
Rev Neurol; 1997 Aug; 25 Suppl 2():S170-9. PubMed ID: 9280685
[TBL] [Abstract][Full Text] [Related]
13. Management of Parkinson's disease a review of current and new therapies.
Mendis T; Suchowersky O; Lang A; Gauthier S
Can J Neurol Sci; 1999 May; 26(2):89-103. PubMed ID: 10352867
[TBL] [Abstract][Full Text] [Related]
14. L-dopa-induced dyskinesia and stereotactic surgery for Parkinson's disease.
Guridi J; Obeso JA; Rodriguez-Oroz MC; Lozano AA; Manrique M
Neurosurgery; 2008 Feb; 62(2):311-23; discussion 323-5. PubMed ID: 18382309
[TBL] [Abstract][Full Text] [Related]
15. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
[TBL] [Abstract][Full Text] [Related]
16. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
17. Options in the treatment of motor fluctuations and dyskinesias in Parkinson's disease: a brief review.
Pahwa R; Lyons KE
Neurol Clin; 2004 Oct; 22(3 Suppl):S35-52. PubMed ID: 15501365
[No Abstract] [Full Text] [Related]
18. Surgical treatments for Parkinson's disease.
Uitti RJ
Can Fam Physician; 2000 Feb; 46():368-73. PubMed ID: 10690493
[TBL] [Abstract][Full Text] [Related]
19. Levodopa unresponsive symptoms in Parkinson disease.
Sethi K
Mov Disord; 2008; 23 Suppl 3():S521-33. PubMed ID: 18781679
[TBL] [Abstract][Full Text] [Related]
20. Future and current surgical therapies in Parkinson's disease.
Betchen SA; Kaplitt M
Curr Opin Neurol; 2003 Aug; 16(4):487-93. PubMed ID: 12869808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
